deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT01850446

Comparative Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza

Comparative Parallel-group Randomized Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza

Sponsor: Materia Medica Holding

Conditions Influenza
Interventions Ergoferon Oseltamivir
Updated 11 times since 2017 Last updated: Apr 15, 2020 Started: Feb 20, 2015 Primary completion: Apr 16, 2018 Completion: Apr 16, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Influenza, this trial is completed. The trial is conducted by Materia Medica Holding and has accumulated 11 data snapshots since 2015. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Jan 2017 – ~Mar 2017 · 59 days · monthly snapshotRecruiting~Mar 2017 – ~Oct 2017 · 7 months · monthly snapshotRecruiting~Oct 2017 – ~Jan 2018 · 3 months · monthly snapshotRecruiting~Jan 2018 – ~Jun 2018 · 5 months · monthly snapshotRecruiting~Jun 2018 – ~Feb 2019 · 8 months · monthly snapshotRecruiting~Feb 2019 – ~May 2020 · 15 months · monthly snapshotCompleted~May 2020 – ~Jan 2021 · 8 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

11 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  5. May 2020 — Jan 2021 [monthly]

    Completed PHASE4

▶ Show 6 earlier versions

  1. Feb 2019 — May 2020 [monthly]

    Completed PHASE4

    Status: Recruiting → Completed

  2. Jun 2018 — Feb 2019 [monthly]

    Recruiting PHASE4

  3. Jan 2018 — Jun 2018 [monthly]

    Recruiting PHASE4

  4. Oct 2017 — Jan 2018 [monthly]

    Recruiting PHASE4

  5. Mar 2017 — Oct 2017 [monthly]

    Recruiting PHASE4

  6. Jan 2017 — Mar 2017 [monthly]

    Recruiting PHASE4

    First recorded

Feb 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Materia Medica Holding
Data source: Materia Medica Holding

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations